Exploring HIV Research in the PrEP Era: Challenges and Opportunities

Join a conversation around the evolving landscape of HIV research amidst the widespread adoption of pre-exposure prophylaxis (PrEP) as the standard of care for HIV prevention. This webinar aims to provide a comprehensive understanding of the unique challenges and opportunities faced by clinical trials evaluating new prevention strategies.

Register Free: https://www.appliedclinicaltrialsonline.com/act/hiv-research

Event overview
Join a conversation around the evolving landscape of HIV research amidst the widespread adoption of pre-exposure prophylaxis (PrEP) as the standard of care for HIV prevention. This webinar aims to provide a comprehensive understanding of the unique challenges and opportunities faced by clinical trials evaluating new prevention strategies.

Three key take-aways

• Trial Design and Endpoint Selection in the PrEP Era: Navigating Complexities
• Participant Recruitment and Ethical Considerations: Balancing Innovation and Standard of Care
• Implementation and Adherence Monitoring: Overcoming Obstacles in the PrEP Era

Speakers:

Pragna Patel, MD, MPH, DTM&H
Chief Medical Officer, Coronaviruses and Other Respiratory Viruses Division
National Center for Immunizations and Respiratory Diseases Centers for Disease Control and Prevention

Dr. Pragna Patel is a physician and epidemiologist with over 25 years of experience in the practice of medicine and public health combined. She is currently the Chief Medical Officer of CDC's Coronavirus and Other Respiratory Viruses Division.

Most recently, she was employed as a Senior Medical and Science Advisor for the Global Health Center, HIV Prevention Branch where she advises on clinical issues and biomedical interventions, such as pre-exposure prophylaxis (PrEP), relevant to adolescent girls and young women and DREAMS. She founded and co-led the PEPFAR interagency PrEP community of practice and is a member of the WHO Global PrEP Coalition. She advised on USAID-funded PrEP projects as a member of the Microbicide Initiative Advisory Board and is a steering committee member of the NIH Adolescent HIV Prevention and Treatment Implementation Science Alliance and the HLB-SIMPLe Alliance.

Since joining the CDC in 2002 until 2013, Dr. Patel worked in the Division of HIV/AIDS Prevention (DHAP) and made numerous notable contributions to DHAP’s mission. She served as a subject matter expert in chronic diseases, especially cancer, among HIV-infected persons, in HIV transmission, and in acute HIV infection. She participated in multiple workgroups and has contributed to seven guideline documents related to HIV prevention, including a new algorithm for HIV testing in the U.S. and PrEP. She also contributed to the creation of the acute HIV infection case definition used for the U.S. National HIV Surveillance System and had been involved in the funding and implementation of 15 studies related to HIV testing and clinical outcomes. She led an HIV cohort study aimed to examine the natural history of HIV/AIDS in the era of effective therapy and was a member of NA-ACCORD.


Richard M. Novak, MD
Head of the Division of Infectious Diseases at UI Health
UI Health

Infectious disease researcher and clinician Dr. Richard Novak has cared for HIV patients for more than 30 years and has been leading the Chicago area in COVID-19 vaccine and treatment research.

His research on HIV focuses on prevention vaccines and microbicides targeted at women at high risk for HIV infection and men who have sex with men.
Novak’s work on COVID-19 has included being the UIC principal investigator of multiple clinical trials sponsored by the National Institutes of Health, including the first clinical trial of a COVID-19 vaccine in Chicago.


Stephen Schrantz, MD
Senior Medical Director
IQVIA

Dr. Steven Schrantz serves as both Senior Medical Director Infectious Diseases & Vaccines and Medical Strategy Lead, Therapeutic Strategy & Science Unit for IQVIA. He has over 15 years of clinical and research experience in both the CRO setting as well as on the faculty at the University of Chicago. He has expertise in Vaccines and Infectious diseases in adults and children: HIV treatment and prevention, Antimicrobials (MDRs), SARS-CoV-2 treatment and prevention. He also serves an infectious disease clinical practice in outpatient clinic in underserved a


Register Free: https://www.appliedclinicaltrialsonline.com/act/hiv-research